Children are therapeutic orphans and an underprivileged group in innovations derived from drug therapy. As the … the lack of innovative activity targeted at drugs for children, though social cost-benefit considerations (i.e. welfare … innovation process of drugs for children, and in improving the uncertain situation of pediatric therapy …